Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Whole-Genome Sequencing to Determine Origin of Multinational Outbreak of Sarocladium kiliense Bloodstream Infections.

Etienne KA, Roe CC, Smith RM, Vallabhaneni S, Duarte C, Escadon P, Castaneda E, Gomez BL, de Bedout C, López LF, Salas V, Hederra LM, Fernandez J, Pidal P, Hormazabel JC, Otaiza F, Vannberg FO, Gillece J, Lemmer D, Driebe EM, Englethaler DM, Litvintseva AP.

Emerg Infect Dis. 2016 Mar;22(3). doi: 10.3201/eid2203.151193.

2.

Compounding drugs contaminated with fungi: a recipe for disaster.

Levitz SM.

Emerg Microbes Infect. 2012 Nov;1(11):e41. doi: 10.1038/emi.2012.46. No abstract available.

3.

U.S. Compounding Pharmacy-Related Outbreaks, 2001-2013: Public Health and Patient Safety Lessons Learned.

Shehab N, Brown MN, Kallen AJ, Perz JF.

J Patient Saf. 2015 May 21. [Epub ahead of print]

PMID:
26001553
4.

Estimated deaths and illnesses averted during fungal meningitis outbreak associated with contaminated steroid injections, United States, 2012-2013.

Smith RM, Derado G, Wise M, Harris JR, Chiller T, Meltzer MI, Park BJ.

Emerg Infect Dis. 2015 Jun;21(6):933-40. doi: 10.3201/eid2106.141558.

5.

Inherited CARD9 deficiency in 2 unrelated patients with invasive Exophiala infection.

Lanternier F, Barbati E, Meinzer U, Liu L, Pedergnana V, Migaud M, Héritier S, Chomton M, Frémond ML, Gonzales E, Galeotti C, Romana S, Jacquemin E, Angoulvant A, Bidault V, Canioni D, Lachenaud J, Mansouri D, Mahdaviani SA, Adimi P, Mansouri N, Jamshidi M, Bougnoux ME, Abel L, Lortholary O, Blanche S, Casanova JL, Picard C, Puel A.

J Infect Dis. 2015 Apr 15;211(8):1241-50. doi: 10.1093/infdis/jiu412. Epub 2014 Jul 23.

6.

Outbreak of Serratia marcescens bloodstream infections in patients receiving parenteral nutrition prepared by a compounding pharmacy.

Gupta N, Hocevar SN, Moulton-Meissner HA, Stevens KM, McIntyre MG, Jensen B, Kuhar DT, Noble-Wang JA, Schnatz RG, Becker SC, Kastango ES, Shehab N, Kallen AJ.

Clin Infect Dis. 2014 Jul 1;59(1):1-8. doi: 10.1093/cid/ciu218. Epub 2014 Apr 11.

7.

Comparative genomic and transcriptomic analysis of wangiella dermatitidis, a major cause of phaeohyphomycosis and a model black yeast human pathogen.

Chen Z, Martinez DA, Gujja S, Sykes SM, Zeng Q, Szaniszlo PJ, Wang Z, Cuomo CA.

G3 (Bethesda). 2014 Apr 16;4(4):561-78. doi: 10.1534/g3.113.009241.

8.

Fungal endophthalmitis associated with compounded products.

Mikosz CA, Smith RM, Kim M, Tyson C, Lee EH, Adams E, Straif-Bourgeois S, Sowadsky R, Arroyo S, Grant-Greene Y, Duran J, Vasquez Y, Robinson BF, Harris JR, Lockhart SR, Török TJ, Mascola L, Park BJ; Fungal Endophthalmitis Outbreak Response Team.

Emerg Infect Dis. 2014 Feb;20(2):248-56. doi: 10.3201/eid2002.131257.

9.

Optimal media for use in air sampling to detect cultivable bacteria and fungi in the pharmacy.

Weissfeld AS, Joseph RA, Le TV, Trevino EA, Schaeffer MF, Vance PH.

J Clin Microbiol. 2013 Oct;51(10):3172-5. doi: 10.1128/JCM.00944-13. Epub 2013 Jul 31.

10.

Vascular complications of fungal meningitis attributed to injections of contaminated methylprednisolone acetate.

Kleinfeld K, Jones P, Riebau D, Beck A, Paueksakon P, Abel T, Claassen DO.

JAMA Neurol. 2013 Sep 1;70(9):1173-6.

11.

Description of outbreaks of health-care-associated infections related to compounding pharmacies, 2000-12.

Staes C, Jacobs J, Mayer J, Allen J.

Am J Health Syst Pharm. 2013 Aug 1;70(15):1301-12. doi: 10.2146/ajhp130049. Review.

12.

Exserohilum infections associated with contaminated steroid injections: a clinicopathologic review of 40 cases.

Ritter JM, Muehlenbachs A, Blau DM, Paddock CD, Shieh WJ, Drew CP, Batten BC, Bartlett JH, Metcalfe MG, Pham CD, Lockhart SR, Patel M, Liu L, Jones TL, Greer PW, Montague JL, White E, Rollin DC, Seales C, Stewart D, Deming MV, Brandt ME, Zaki SR; Exserohilum Infections Working Group.

Am J Pathol. 2013 Sep;183(3):881-92. doi: 10.1016/j.ajpath.2013.05.007. Epub 2013 Jun 26.

13.

Straight from the headlines: what is going on in compounding pharmacies, and how can clinical microbiologists help?

Weissfeld AS.

J Clin Microbiol. 2013 Oct;51(10):3168-71. doi: 10.1128/JCM.00160-13. Epub 2013 Jun 19. Review. No abstract available.

14.

Preliminary laboratory report of fungal infections associated with contaminated methylprednisolone injections.

Lockhart SR, Pham CD, Gade L, Iqbal N, Scheel CM, Cleveland AA, Whitney AM, Noble-Wang J, Chiller TM, Park BJ, Litvintseva AP, Brandt ME.

J Clin Microbiol. 2013 Aug;51(8):2654-61. doi: 10.1128/JCM.01000-13. Epub 2013 Jun 12.

15.

Potential risks of pharmacy compounding.

Gudeman J, Jozwiakowski M, Chollet J, Randell M.

Drugs R D. 2013 Mar;13(1):1-8. doi: 10.1007/s40268-013-0005-9. Review.

16.

Reflections on the approach to treatment of a mycologic disaster.

Stevens DA.

Antimicrob Agents Chemother. 2013 Apr;57(4):1567-72. doi: 10.1128/AAC.02242-12. Epub 2013 Feb 5. No abstract available.

17.

Exserohilum rostratum fungal meningitis associated with methylprednisolone injections.

Casadevall A, Pirofski LA.

Future Microbiol. 2013 Feb;8(2):135-7. doi: 10.2217/fmb.12.138. No abstract available.

18.

Fungal infections associated with contaminated methylprednisolone in Tennessee.

Kainer MA, Reagan DR, Nguyen DB, Wiese AD, Wise ME, Ward J, Park BJ, Kanago ML, Baumblatt J, Schaefer MK, Berger BE, Marder EP, Min JY, Dunn JR, Smith RM, Dreyzehner J, Jones TF; Tennessee Fungal Meningitis Investigation Team.

N Engl J Med. 2012 Dec 6;367(23):2194-203. doi: 10.1056/NEJMoa1212972. Epub 2012 Nov 6.

19.

Survey of sterile admixture practices in canadian hospital pharmacies: part 1. Methods and results.

Warner T, Nishi C, Checkowski R, Hall KW.

Can J Hosp Pharm. 2009 Mar;62(2):100-11.

20.

Hospital epidemiology and infection control in acute-care settings.

Sydnor ER, Perl TM.

Clin Microbiol Rev. 2011 Jan;24(1):141-73. doi: 10.1128/CMR.00027-10. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk